Regulation

Optimizing the upscaling and outscaling of CAR T-cell therapies 4:06
Optimizing the upscaling and outscaling of CAR T-cell therapies
Saskia Rösch • 6 Apr 2022
The importance of collaboration in cell and gene therapy development 2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh • 27 Jan 2022
Improving the scalability of advanced therapies 2:27
Improving the scalability of advanced therapies
Delara Motlagh • 27 Jan 2022
Strategies for large scale viral vector development 1:41
Strategies for large scale viral vector development
Rachel Legmann • 27 Jan 2022
Building collaborative relationships to overcome challenges in the CGT industry 2:46
Building collaborative relationships to overcome challenges in the CGT industry
Sharon Brownlow • 26 Jan 2022
Regulatory challenges in automating CGT manufacturing 1:04
Regulatory challenges in automating CGT manufacturing
Delara Motlagh • 27 Jan 2022
The role of ARM in the cell and gene therapy industry 1:04
The role of ARM in the cell and gene therapy industry
Michael Lehmicke • 26 Jan 2022
The impact of COVID-19 on the advanced therapy sector 1:36
The impact of COVID-19 on the advanced therapy sector
Michael Lehmicke • 26 Jan 2022
Clinical challenges in developing AAV-based gene therapies 0:55
Clinical challenges in developing AAV-based gene therapies
Christopher Reardon • 27 Jan 2022
Achieving operational excellence in CGT through automation 4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow • 26 Jan 2022
Addressing labor and educational gaps in the CGT industry 1:18
Addressing labor and educational gaps in the CGT industry
Michael Lehmicke • 26 Jan 2022
Upscaling cell and gene therapy manufacturing 1:18
Upscaling cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
A 2022 update of the Alliance for Regenerative Medicine 0:52
A 2022 update of the Alliance for Regenerative Medicine
Janet Lynch Lambert • 26 Jan 2022
The need for standardization in cell and gene therapy manufacturing 2:14
The need for standardization in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
CMC challenges in cell and gene therapy manufacturing 1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
Addressing issues in the clinical translation of cell & gene therapies 3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert • 26 Jan 2022
The content of VJRegenMed is intended for healthcare professionals